The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Controlled Substances Market Research Report 2024
Synopsis
A controlled substance is generally a drug or chemical whose manufacture, possession, or use is regulated by a government, such as illicitly used drugs or prescription medications that are designated by law.
The global Controlled Substances market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Drugs and other substances that are considered controlled substances under the Controlled Substances Act (CSA) are classified into five schedules. This scheduling is depended on the drug’s acceptable medical use and the drug’s abuse or dependency potential. The CSA scheduling list is annually updated and describes basic or parent chemical. This list is not comprehensive and does not describe salts, isomers, and salts of isomers, esters, ethers, and derivatives.
This report aims to provide a comprehensive presentation of the global market for Controlled Substances, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Controlled Substances.
Report Scope
The Controlled Substances market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Controlled Substances market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Controlled Substances companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Pfizer
Siegfried AG
GlaxoSmithKline
Teva Pharmaceuticals
Viatris
Takeda Pharmaceutical
Sun Pharmaceutical
Daiichi Sankyo
Akorn Inc
Tilray
Medical Marijuana, Inc
Consort Medical
Purdue Pharma
Segment by Type
Opioids
Stimulants
Depressants
Marijuana
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Controlled Substances companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A controlled substance is generally a drug or chemical whose manufacture, possession, or use is regulated by a government, such as illicitly used drugs or prescription medications that are designated by law.
The global Controlled Substances market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Drugs and other substances that are considered controlled substances under the Controlled Substances Act (CSA) are classified into five schedules. This scheduling is depended on the drug’s acceptable medical use and the drug’s abuse or dependency potential. The CSA scheduling list is annually updated and describes basic or parent chemical. This list is not comprehensive and does not describe salts, isomers, and salts of isomers, esters, ethers, and derivatives.
This report aims to provide a comprehensive presentation of the global market for Controlled Substances, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Controlled Substances.
Report Scope
The Controlled Substances market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Controlled Substances market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Controlled Substances companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Pfizer
Siegfried AG
GlaxoSmithKline
Teva Pharmaceuticals
Viatris
Takeda Pharmaceutical
Sun Pharmaceutical
Daiichi Sankyo
Akorn Inc
Tilray
Medical Marijuana, Inc
Consort Medical
Purdue Pharma
Segment by Type
Opioids
Stimulants
Depressants
Marijuana
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Controlled Substances companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Controlled Substances Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Opioids
1.2.3 Stimulants
1.2.4 Depressants
1.2.5 Marijuana
1.2.6 Others
1.3 Market by Application
1.3.1 Global Controlled Substances Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Controlled Substances Market Perspective (2019-2030)
2.2 Controlled Substances Growth Trends by Region
2.2.1 Global Controlled Substances Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Controlled Substances Historic Market Size by Region (2019-2024)
2.2.3 Controlled Substances Forecasted Market Size by Region (2025-2030)
2.3 Controlled Substances Market Dynamics
2.3.1 Controlled Substances Industry Trends
2.3.2 Controlled Substances Market Drivers
2.3.3 Controlled Substances Market Challenges
2.3.4 Controlled Substances Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Controlled Substances Players by Revenue
3.1.1 Global Top Controlled Substances Players by Revenue (2019-2024)
3.1.2 Global Controlled Substances Revenue Market Share by Players (2019-2024)
3.2 Global Controlled Substances Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Controlled Substances Revenue
3.4 Global Controlled Substances Market Concentration Ratio
3.4.1 Global Controlled Substances Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Controlled Substances Revenue in 2023
3.5 Controlled Substances Key Players Head office and Area Served
3.6 Key Players Controlled Substances Product Solution and Service
3.7 Date of Enter into Controlled Substances Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Controlled Substances Breakdown Data by Type
4.1 Global Controlled Substances Historic Market Size by Type (2019-2024)
4.2 Global Controlled Substances Forecasted Market Size by Type (2025-2030)
5 Controlled Substances Breakdown Data by Application
5.1 Global Controlled Substances Historic Market Size by Application (2019-2024)
5.2 Global Controlled Substances Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Controlled Substances Market Size (2019-2030)
6.2 North America Controlled Substances Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Controlled Substances Market Size by Country (2019-2024)
6.4 North America Controlled Substances Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Controlled Substances Market Size (2019-2030)
7.2 Europe Controlled Substances Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Controlled Substances Market Size by Country (2019-2024)
7.4 Europe Controlled Substances Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Controlled Substances Market Size (2019-2030)
8.2 Asia-Pacific Controlled Substances Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Controlled Substances Market Size by Region (2019-2024)
8.4 Asia-Pacific Controlled Substances Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Controlled Substances Market Size (2019-2030)
9.2 Latin America Controlled Substances Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Controlled Substances Market Size by Country (2019-2024)
9.4 Latin America Controlled Substances Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Controlled Substances Market Size (2019-2030)
10.2 Middle East & Africa Controlled Substances Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Controlled Substances Market Size by Country (2019-2024)
10.4 Middle East & Africa Controlled Substances Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Controlled Substances Introduction
11.1.4 Johnson & Johnson Revenue in Controlled Substances Business (2019-2024)
11.1.5 Johnson & Johnson Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Controlled Substances Introduction
11.2.4 Pfizer Revenue in Controlled Substances Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 Siegfried AG
11.3.1 Siegfried AG Company Detail
11.3.2 Siegfried AG Business Overview
11.3.3 Siegfried AG Controlled Substances Introduction
11.3.4 Siegfried AG Revenue in Controlled Substances Business (2019-2024)
11.3.5 Siegfried AG Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Detail
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Controlled Substances Introduction
11.4.4 GlaxoSmithKline Revenue in Controlled Substances Business (2019-2024)
11.4.5 GlaxoSmithKline Recent Development
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Detail
11.5.2 Teva Pharmaceuticals Business Overview
11.5.3 Teva Pharmaceuticals Controlled Substances Introduction
11.5.4 Teva Pharmaceuticals Revenue in Controlled Substances Business (2019-2024)
11.5.5 Teva Pharmaceuticals Recent Development
11.6 Viatris
11.6.1 Viatris Company Detail
11.6.2 Viatris Business Overview
11.6.3 Viatris Controlled Substances Introduction
11.6.4 Viatris Revenue in Controlled Substances Business (2019-2024)
11.6.5 Viatris Recent Development
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Detail
11.7.2 Takeda Pharmaceutical Business Overview
11.7.3 Takeda Pharmaceutical Controlled Substances Introduction
11.7.4 Takeda Pharmaceutical Revenue in Controlled Substances Business (2019-2024)
11.7.5 Takeda Pharmaceutical Recent Development
11.8 Sun Pharmaceutical
11.8.1 Sun Pharmaceutical Company Detail
11.8.2 Sun Pharmaceutical Business Overview
11.8.3 Sun Pharmaceutical Controlled Substances Introduction
11.8.4 Sun Pharmaceutical Revenue in Controlled Substances Business (2019-2024)
11.8.5 Sun Pharmaceutical Recent Development
11.9 Daiichi Sankyo
11.9.1 Daiichi Sankyo Company Detail
11.9.2 Daiichi Sankyo Business Overview
11.9.3 Daiichi Sankyo Controlled Substances Introduction
11.9.4 Daiichi Sankyo Revenue in Controlled Substances Business (2019-2024)
11.9.5 Daiichi Sankyo Recent Development
11.10 Akorn Inc
11.10.1 Akorn Inc Company Detail
11.10.2 Akorn Inc Business Overview
11.10.3 Akorn Inc Controlled Substances Introduction
11.10.4 Akorn Inc Revenue in Controlled Substances Business (2019-2024)
11.10.5 Akorn Inc Recent Development
11.11 Tilray
11.11.1 Tilray Company Detail
11.11.2 Tilray Business Overview
11.11.3 Tilray Controlled Substances Introduction
11.11.4 Tilray Revenue in Controlled Substances Business (2019-2024)
11.11.5 Tilray Recent Development
11.12 Medical Marijuana, Inc
11.12.1 Medical Marijuana, Inc Company Detail
11.12.2 Medical Marijuana, Inc Business Overview
11.12.3 Medical Marijuana, Inc Controlled Substances Introduction
11.12.4 Medical Marijuana, Inc Revenue in Controlled Substances Business (2019-2024)
11.12.5 Medical Marijuana, Inc Recent Development
11.13 Consort Medical
11.13.1 Consort Medical Company Detail
11.13.2 Consort Medical Business Overview
11.13.3 Consort Medical Controlled Substances Introduction
11.13.4 Consort Medical Revenue in Controlled Substances Business (2019-2024)
11.13.5 Consort Medical Recent Development
11.14 Purdue Pharma
11.14.1 Purdue Pharma Company Detail
11.14.2 Purdue Pharma Business Overview
11.14.3 Purdue Pharma Controlled Substances Introduction
11.14.4 Purdue Pharma Revenue in Controlled Substances Business (2019-2024)
11.14.5 Purdue Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Controlled Substances Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Opioids
Table 3. Key Players of Stimulants
Table 4. Key Players of Depressants
Table 5. Key Players of Marijuana
Table 6. Key Players of Others
Table 7. Global Controlled Substances Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Controlled Substances Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Controlled Substances Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Controlled Substances Market Share by Region (2019-2024)
Table 11. Global Controlled Substances Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Controlled Substances Market Share by Region (2025-2030)
Table 13. Controlled Substances Market Trends
Table 14. Controlled Substances Market Drivers
Table 15. Controlled Substances Market Challenges
Table 16. Controlled Substances Market Restraints
Table 17. Global Controlled Substances Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Controlled Substances Market Share by Players (2019-2024)
Table 19. Global Top Controlled Substances Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Controlled Substances as of 2023)
Table 20. Ranking of Global Top Controlled Substances Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Controlled Substances Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Controlled Substances Product Solution and Service
Table 24. Date of Enter into Controlled Substances Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Controlled Substances Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Controlled Substances Revenue Market Share by Type (2019-2024)
Table 28. Global Controlled Substances Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Controlled Substances Revenue Market Share by Type (2025-2030)
Table 30. Global Controlled Substances Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Controlled Substances Revenue Market Share by Application (2019-2024)
Table 32. Global Controlled Substances Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Controlled Substances Revenue Market Share by Application (2025-2030)
Table 34. North America Controlled Substances Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Controlled Substances Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Controlled Substances Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Controlled Substances Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Controlled Substances Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Controlled Substances Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Controlled Substances Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Controlled Substances Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Controlled Substances Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Controlled Substances Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Controlled Substances Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Controlled Substances Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Controlled Substances Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Controlled Substances Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Controlled Substances Market Size by Country (2025-2030) & (US$ Million)
Table 49. Johnson & Johnson Company Detail
Table 50. Johnson & Johnson Business Overview
Table 51. Johnson & Johnson Controlled Substances Product
Table 52. Johnson & Johnson Revenue in Controlled Substances Business (2019-2024) & (US$ Million)
Table 53. Johnson & Johnson Recent Development
Table 54. Pfizer Company Detail
Table 55. Pfizer Business Overview
Table 56. Pfizer Controlled Substances Product
Table 57. Pfizer Revenue in Controlled Substances Business (2019-2024) & (US$ Million)
Table 58. Pfizer Recent Development
Table 59. Siegfried AG Company Detail
Table 60. Siegfried AG Business Overview
Table 61. Siegfried AG Controlled Substances Product
Table 62. Siegfried AG Revenue in Controlled Substances Business (2019-2024) & (US$ Million)
Table 63. Siegfried AG Recent Development
Table 64. GlaxoSmithKline Company Detail
Table 65. GlaxoSmithKline Business Overview
Table 66. GlaxoSmithKline Controlled Substances Product
Table 67. GlaxoSmithKline Revenue in Controlled Substances Business (2019-2024) & (US$ Million)
Table 68. GlaxoSmithKline Recent Development
Table 69. Teva Pharmaceuticals Company Detail
Table 70. Teva Pharmaceuticals Business Overview
Table 71. Teva Pharmaceuticals Controlled Substances Product
Table 72. Teva Pharmaceuticals Revenue in Controlled Substances Business (2019-2024) & (US$ Million)
Table 73. Teva Pharmaceuticals Recent Development
Table 74. Viatris Company Detail
Table 75. Viatris Business Overview
Table 76. Viatris Controlled Substances Product
Table 77. Viatris Revenue in Controlled Substances Business (2019-2024) & (US$ Million)
Table 78. Viatris Recent Development
Table 79. Takeda Pharmaceutical Company Detail
Table 80. Takeda Pharmaceutical Business Overview
Table 81. Takeda Pharmaceutical Controlled Substances Product
Table 82. Takeda Pharmaceutical Revenue in Controlled Substances Business (2019-2024) & (US$ Million)
Table 83. Takeda Pharmaceutical Recent Development
Table 84. Sun Pharmaceutical Company Detail
Table 85. Sun Pharmaceutical Business Overview
Table 86. Sun Pharmaceutical Controlled Substances Product
Table 87. Sun Pharmaceutical Revenue in Controlled Substances Business (2019-2024) & (US$ Million)
Table 88. Sun Pharmaceutical Recent Development
Table 89. Daiichi Sankyo Company Detail
Table 90. Daiichi Sankyo Business Overview
Table 91. Daiichi Sankyo Controlled Substances Product
Table 92. Daiichi Sankyo Revenue in Controlled Substances Business (2019-2024) & (US$ Million)
Table 93. Daiichi Sankyo Recent Development
Table 94. Akorn Inc Company Detail
Table 95. Akorn Inc Business Overview
Table 96. Akorn Inc Controlled Substances Product
Table 97. Akorn Inc Revenue in Controlled Substances Business (2019-2024) & (US$ Million)
Table 98. Akorn Inc Recent Development
Table 99. Tilray Company Detail
Table 100. Tilray Business Overview
Table 101. Tilray Controlled Substances Product
Table 102. Tilray Revenue in Controlled Substances Business (2019-2024) & (US$ Million)
Table 103. Tilray Recent Development
Table 104. Medical Marijuana, Inc Company Detail
Table 105. Medical Marijuana, Inc Business Overview
Table 106. Medical Marijuana, Inc Controlled Substances Product
Table 107. Medical Marijuana, Inc Revenue in Controlled Substances Business (2019-2024) & (US$ Million)
Table 108. Medical Marijuana, Inc Recent Development
Table 109. Consort Medical Company Detail
Table 110. Consort Medical Business Overview
Table 111. Consort Medical Controlled Substances Product
Table 112. Consort Medical Revenue in Controlled Substances Business (2019-2024) & (US$ Million)
Table 113. Consort Medical Recent Development
Table 114. Purdue Pharma Company Detail
Table 115. Purdue Pharma Business Overview
Table 116. Purdue Pharma Controlled Substances Product
Table 117. Purdue Pharma Revenue in Controlled Substances Business (2019-2024) & (US$ Million)
Table 118. Purdue Pharma Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Controlled Substances Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Controlled Substances Market Share by Type: 2023 VS 2030
Figure 3. Opioids Features
Figure 4. Stimulants Features
Figure 5. Depressants Features
Figure 6. Marijuana Features
Figure 7. Others Features
Figure 8. Global Controlled Substances Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Controlled Substances Market Share by Application: 2023 VS 2030
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Online Pharmacies Case Studies
Figure 13. Controlled Substances Report Years Considered
Figure 14. Global Controlled Substances Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Controlled Substances Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Controlled Substances Market Share by Region: 2023 VS 2030
Figure 17. Global Controlled Substances Market Share by Players in 2023
Figure 18. Global Top Controlled Substances Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Controlled Substances as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Controlled Substances Revenue in 2023
Figure 20. North America Controlled Substances Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Controlled Substances Market Share by Country (2019-2030)
Figure 22. United States Controlled Substances Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Controlled Substances Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Controlled Substances Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Controlled Substances Market Share by Country (2019-2030)
Figure 26. Germany Controlled Substances Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Controlled Substances Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Controlled Substances Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Controlled Substances Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Controlled Substances Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Controlled Substances Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Controlled Substances Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Controlled Substances Market Share by Region (2019-2030)
Figure 34. China Controlled Substances Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Controlled Substances Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Controlled Substances Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Controlled Substances Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Controlled Substances Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Controlled Substances Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Controlled Substances Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Controlled Substances Market Share by Country (2019-2030)
Figure 42. Mexico Controlled Substances Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Controlled Substances Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Controlled Substances Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Controlled Substances Market Share by Country (2019-2030)
Figure 46. Turkey Controlled Substances Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Controlled Substances Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Johnson & Johnson Revenue Growth Rate in Controlled Substances Business (2019-2024)
Figure 49. Pfizer Revenue Growth Rate in Controlled Substances Business (2019-2024)
Figure 50. Siegfried AG Revenue Growth Rate in Controlled Substances Business (2019-2024)
Figure 51. GlaxoSmithKline Revenue Growth Rate in Controlled Substances Business (2019-2024)
Figure 52. Teva Pharmaceuticals Revenue Growth Rate in Controlled Substances Business (2019-2024)
Figure 53. Viatris Revenue Growth Rate in Controlled Substances Business (2019-2024)
Figure 54. Takeda Pharmaceutical Revenue Growth Rate in Controlled Substances Business (2019-2024)
Figure 55. Sun Pharmaceutical Revenue Growth Rate in Controlled Substances Business (2019-2024)
Figure 56. Daiichi Sankyo Revenue Growth Rate in Controlled Substances Business (2019-2024)
Figure 57. Akorn Inc Revenue Growth Rate in Controlled Substances Business (2019-2024)
Figure 58. Tilray Revenue Growth Rate in Controlled Substances Business (2019-2024)
Figure 59. Medical Marijuana, Inc Revenue Growth Rate in Controlled Substances Business (2019-2024)
Figure 60. Consort Medical Revenue Growth Rate in Controlled Substances Business (2019-2024)
Figure 61. Purdue Pharma Revenue Growth Rate in Controlled Substances Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
